Opportunities for Proteomics Technology Markets in Europe

Table of Contents

• 1. Executive Summary
  • 1. Industry Snapshot
    • 1. Executive Summary
• 2. Glossary
  • 1. Glossary of Terms
    • 1. Glossary
  • 2. Exchange Rates
    • 1. Exchange Rates
• 3. Total Market
  • 1. Market Overview
    • 1. Market Overview and Definition
  • 2. Segmentation
    • 1. Segmentation
  • 3. Market Engineering Measurements
    • 1. Market Engineering Measurements
  • 4. Market Drivers
    • 1. Drivers
  • 5. Industry Challenges
    • 1. Industry Challenges
  • 6. Total European Revenue Forecasts
    • 1. Revenue Forecasts
  • 7. End-user Segmentation
    • 1. End-user Trends
  • 8. Technology Trends
    • 1. Technology Trends
  • 9. Competitive Landscape
    • 1. Competitive Structure
  • 10. Funding Landscape-Germany
    • 1. Funding Landscape
  • 11. Funding Landscape -United Kingdom
    • 1. Funding Scenario
• 4. Protein Separation Technology
  • 1. Introduction
    • 1. Background
  • 2. Market Engineering Measurements
    • 1. Market Engineering Measurements
  • 3. Revenue Forecasts
    • 1. Revenue Forecasts
• 5. Protein Identification Technology
  • 1. Background
    • 1. Overview
  • 2. Market Engineering Measurements
    • 1. Market Engineering Measurements
  • 3. Revenue Forecasts
    • 1. Revenue Forecasts
• 6. Strategic Recommendations
  • 1. Strategic Recommendations
    • 1. Possible Strategies
• 7. DSD for Proteomics
  • 1. Private Investment for Biotechnology
    • 1. Private Investment in Biotechnology
  • 2. Pharmaceutical R&D Expenditure
    • 1. Pharmaceutical R&D Expenditure
  • 3. Biotech Companies and Number of Employees
    • 1. Biotech Companies
    • 2. Number of Employees
  • 4. Pharmaceutical R&D Expenditure as a percentage of the Pharmaceutical Market
    • 1. Pharmaceutical R&D Expenditure as a Percent of Pharmaceutical Market
• 8. Database of key Industry Participants(DKIP)
  • 1. Database of Key Industry Participants
    • 1. Database of Key Industry Participants